title: Genetic alterations in B-cell non-Hodgkin's lymphoma.
abstract: BACKGROUND
  Although the patients with diagnosed B-NHL are classified into the same disease stage on the basis of clinical, histopathological, and immunological parameters, they respond significantly different to the applied treatment. This points out the possibility that within the same group of lymphoma there are different diseases at molecular level. For that reason many studies deal with the detection of gene alterations in lymphomas to provide a better framework for diagnosis and treatment of these hematological malignancies.
  
  
  OBJECTIVE
  To define genetic alterations in the B-NHL with highest possibilites for diagnostic purposes and molecular detection of MRD.
  
  
  METHODS
  Formalin fixed and paraffin embedded lymph node tissues from 45 patients were examined by different PCR techniques for the presence of IgH and TCR gamma gene rearrangement; K-ras and H-ras mutations; c-myc amplification and bcl-2 translocation. There were 34 cases of B-cell non-Hodgkin's lymphoma (B-NHL), 5 cases of T-cell non-Hodgkin's lymphoma (T-NHL) and 6 cases of chronic lymphadenitis (CL). The mononuclear cell fraction of the peripheral blood of 12 patients with B-NHL was analyzed for the presence of monoclonality at the time of diagnosis and in 3 to 6 months time intervals after an autologous bone marrow transplantation (BMT).
  
  
  RESULTS
  The monoclonality of B-lymphocytes, as evidenced by DNA fragment length homogeneity, was detected in 88 % (30/34) of B-NHL, but never in CL, T-NHL, or in normal PBL. Bcl-2 translocation was detected in 7/31 (22.6%) B-NHL specimens, c-myc amplification 9/31 (29%, all were more than doubled), K-ras mutations in 1/31 (3.23%) and H-ras mutations in 2/31 (6.45%) of the examined B-NHL samples. In the case of LC and normal PBL, however, these gene alterations were not detected. All the patients (12) with B-NHL had dominant clone of B-lymphocyte in the peripheral blood at the time of diagnosis while only in 2 of 12 patients MRD was detected 3 or 6 months after BMT.
  
  
  CONCLUSIONS
  Because it is quic and simple, PCR analysis of clonal IgH rearrangements is very useful when diagnostic assistance is required. This technique is also very effecient for tracking minimal residual disease in lymphomas and leukemias and for monitoring clonal evolution in acute and chronic lymphoblastic leukemias and lymphomas. The presence of other genetic alterations, which we detected, should serve as an additional prognostic or predictive factor in the patients with B-NHL.
authors.affiliation: Military Medical Academy, Institute for Medical Research, Belgrade. vmaimi@eunet.yu
authors.forename: Zvonko
authors.initials: Z
authors.lastname: Magić
authors.forename: Tamara
authors.initials: T
authors.lastname: Novković
authors.forename: Bojana
authors.initials: B
authors.lastname: Cikota
authors.forename: Olga
authors.initials: O
authors.lastname: Tasić-Radić
authors.forename: Olivera
authors.initials: O
authors.lastname: Tarabar
authors.forename: Dragana
authors.initials: D
authors.lastname: Stamatović
mesh_terms: D015334:Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor / Q000235:genetics; D005819:Genetic Markers; D006801:Humans; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000235:genetics*; D017354:Point Mutation; D011519:Proto-Oncogenes / Q000235:genetics; D014178:Translocation, Genetic
chemical_list: D005819:Genetic Markers